4.6 Article

Imaging Essential Tremor

Journal

MOVEMENT DISORDERS
Volume 25, Issue 6, Pages 679-686

Publisher

WILEY
DOI: 10.1002/mds.22870

Keywords

essential tremor; SPECT

Funding

  1. Parkinson's Disease Foundation

Ask authors/readers for more resources

To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-omega-fluoropropyl-2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [Tc-99m]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akinetic-rigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET. (C) 2010 Movement Disorder Society

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Oscillatory EEG-TMS Reactivity in Parkinson Disease

Emanuela Formaggio, Michele Tonellato, Angelo Antonini, Leonora Castiglia, Laura Gallo, Paolo Manganotti, Stefano Masiero, Alessandra Del Felice

Summary: This study aims to explore the pathophysiological mechanisms of Parkinson disease (PD) by examining changes in EEG rhythms after transcranial magnetic stimulation (TMS). The study found that TMS can temporarily normalize brain oscillations in PD patients, providing a theoretical basis for the development of practical, portable techniques to treat PD symptoms.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2023)

Article Neurosciences

Adaptive and pathological connectivity responses in Parkinson's disease brain networks

An Vo, Katharina A. Schindlbeck, Nha Nguyen, Andrea Rommal, Phoebe G. Spetsieris, Chris C. Tang, Yoon Young Choi, Martin Niethammer, Vijay Dhawan, David Eidelberg

Summary: Functional imaging is widely used to identify disease-specific networks in neurodegenerative disorders. In Parkinson's disease, network assortativity increases over time, with high assortativity associated with clinically aggressive genetic variants and low assortativity associated with genes related to slow progression.

CEREBRAL CORTEX (2023)

Review Clinical Neurology

Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach

Andrew Lees, Eduardo Tolosa, Fabrizio Stocchi, Joaquim J. Ferreira, Olivier Rascol, Angelo Antonini, Werner Poewe

Summary: There is a resurgence of levodopa as the initial treatment for Parkinson's disease, while the addition of adjuvant treatments is an established strategy to reduce motor complications. Improving levodopa delivery to the brain and combining agents earlier in the disease course can leverage the full potential of this strategy.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2023)

Article Clinical Neurology

Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes

Marta Campagnolo, Luca Weis, Carmelo Fogliano, Valeria Cianci, Michela Garon, Eleonora Fiorenzato, Miryam Carecchio, Florinda Ferreri, Patrizia Bisiacchi, Angelo Antonini, Roberta Biundo

Summary: The International Parkinson's and Movement Disorder Society (MDS) criteria has expanded the clinical spectrum of progressive supranuclear palsy (PSP) and established phenotypic characterization based on the predominant manifestation at onset. This study aimed to describe the clinical/cognitive and imaging features of a monocentric cohort of PSP patients, highlighting different patterns of functional disability according to the assigned phenotype. The findings support the concept of discrete patterns of Tau pathology within the PSP spectrum and emphasize the importance of tailored approaches in terms of follow-up and treatment.

JOURNAL OF NEURAL TRANSMISSION (2023)

Article Clinical Neurology

Impact of advanced Parkinson's disease on caregivers: an international real-world study

Pablo Martinez-Martin, Matej Skorvanek, Tove Henriksen, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Prasanna L. L. Kandukuri, Vivek S. S. Chaudhari, Apeksha B. B. Patel, Juan Carlos Parra, James Pike, Angelo Antonini

Summary: This study examines the impact of advanced Parkinson's disease (APD) on caregiver burden, quality of life (QoL), and health status. The results show that caregivers of people with APD experience a greater burden, are less satisfied with treatment, and spend more time caregiving.

JOURNAL OF NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

ACE2 Receptor and TMPRSS2 Protein Expression Patterns in the Human Brainstem Reveal Anatomical Regions Potentially Vulnerable to SARS-CoV-2 Infection

Aron Emmi, Aleksandar Tushevski, Alessandro Sinigaglia, Silvia Barbon, Michele Sandre, Elena Stocco, Veronica Macchi, Angelo Antonini, Luisa Barzon, Andrea Porzionato, Raffaele De Caro

Summary: Angiotensin-converting enzyme 2 receptor (ACE2R) is a transmembrane protein that plays a key role in blood pressure regulation. It has gained attention for its involvement in the pathogenesis of COVID-19. This study investigated the expression of ACE2R and TMPRSS2 in the brainstem and found that they are expressed in neuronal and glial cells, particularly in specific nuclei. These findings help to understand the neurological manifestations of COVID-19.

ACS CHEMICAL NEUROSCIENCE (2023)

Letter Clinical Neurology

Confusion of evidence-based reviews and guidelines

Gunther Deuschl, Angelo Antonini, Joao Costa, Katarzyna Smilowska, Daniela Berg, Jean-Christophe Corvol, Giovanni Fabbrini, Joaquim Ferreira, Tom Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evzen Ruzicka, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Non-motor effects of deep brain stimulation in Parkinson?s disease motor subtypes

Stefanie T. Jost, Agni Konitsioti, Philipp A. Loehrer, Keyoumars Ashkan, Alexandra Rizos, Anna Sauerbier, Maria Gabriela dos Santos Ghilardi, Franz Rosenkranz, Lena Strobel, Alexandra Gronostay, Michael T. Barbe, Julian Evans, Veerle Visser-Vandewalle, Christopher Nimsky, Gereon R. Fink, Monty Silverdale, Rubens G. Cury, Erich T. Fonoff, Angelo Antonini, K. Ray Chaudhuri, Lars Timmermann, Pablo Martinez-Martin, Haidar S. Dafsari

Summary: This study suggests that patients with 'postural instability and gait difficulty' (PIGD) may experience more beneficial non-motor effects compared to patients with 'tremor-dominant' symptoms undergoing deep brain stimulation (DBS) for Parkinson's disease (PD). These differences in clinical efficacy on non-motor aspects should be taken into consideration when advising and monitoring PD patients undergoing DBS.

PARKINSONISM & RELATED DISORDERS (2023)

Article Chemistry, Analytical

Co-Designing Digital Technologies for Improving Clinical Care in People with Parkinson's Disease: What Did We Learn?

Mariana H. G. Monje, Sylvie Grosjean, Martin Srp, Laura Antunes, Raquel Bouca-Machado, Ricardo Cacho, Sergio Dominguez, John Inocentes, Timothy Lynch, Argyri Tsakanika, Dimitrios Fotiadis, George Rigas, Evzen Ruzicka, Joaquim Ferreira, Angelo Antonini, Norberto Malpica, Tiago Mestre, Alvaro Sanchez-Ferro

Summary: The healthcare model is shifting towards integrated care approaches that involve patients more closely. The iCARE-PD project aims to develop a technology-enabled, home-based, and community-centered integrated care paradigm to address this need. The project's central focus is the codesign process of the care model, with active patient participation in designing and iteratively evaluating sensor-based technological solutions. The results show the usefulness of this approach in testing usability and acceptability, as well as incorporating patients' feedback into the development.

SENSORS (2023)

Article Biotechnology & Applied Microbiology

Pallidal Recordings in Chronically Implanted Dystonic Patients: Mitigation of Tremor-Related Artifacts

Jasmin Del Vecchio Del Vecchio, Ibrahem Hanafi, Nicolo Gabriele Pozzi, Philipp Capetian, Ioannis U. Isaias, Stefan Haufe, Chiara Palmisano

Summary: Low-frequency oscillations in the pallidal local field potentials (LFPs) can be used as a physiomarker for dystonia and personalized adaptive deep brain stimulation. However, head tremor can cause movement artifacts in the LFP signals, which affects the reliability of low-frequency oscillations as biomarkers. This study investigated the pallidal LFPs in dystonia patients and used regression analysis to identify and remove tremor-related artifacts, with the inertial measurement unit (IMU) regression showing better results than electromyographic signal (EMG) regression in artifact removal.

BIOENGINEERING-BASEL (2023)

Review Pharmacology & Pharmacy

The pharmacological management of the behavioral aspects of Parkinson's disease: an update

Marta Campagnolo, Aron Emmi, Roberta Biundo, Eleonora Fiorenzato, Lucia Batzu, K. Ray Chaudhuri, Angelo Antonini

Summary: Behavioural symptoms in Parkinson's disease, including depression, anxiety, impulse control disorders, hallucinations, psychosis, and cognitive dysfunction, are often overlooked and not adequately addressed in many patients. Current literature suggests refraining from using dopamine agonists without considering their potential benefits on motor complications.

EXPERT OPINION ON PHARMACOTHERAPY (2023)

Review Clinical Neurology

Objective measurement versus clinician-based assessment for Parkinson's disease

Andrea Guerra, Valentina D'Onofrio, Florinda Ferreri, Matteo Bologna, Angelo Antonini

Summary: Although clinician-based assessment is the gold standard for quantifying motor impairment in Parkinson's disease, there are limitations such as variability and approximation. Objective motion analyses can complement clinical assessment and provide more accurate evaluations of motor symptoms and complications in PD.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2023)

Article Clinical Neurology

Exploring depression in Alzheimer's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management

Alessandro Padovani, Angelo Antonini, Paolo Barone, Giuseppe Bellelli, Andrea Fagiolini, Luigi Ferini Strambi, Sandro Sorbi, Fabrizio Stocchi

Summary: This Delphi study aims to reach a shared point of view among Italian specialists on depression in Alzheimer's disease (AD). Consensus was achieved in most cases (86%), with 80% of statements receiving positive consensus and 6% receiving negative consensus. The study also highlights the strong link between depression and AD, as well as specific features of depression in AD compared to major depressive disorder (MDD).

NEUROLOGICAL SCIENCES (2023)

Article Neuroimaging

Parkinson's disease progression: Increasing expression of an invariant common core subnetwork

Phoebe G. Spetsieris, David Eidelberg

Summary: Notable progress has been made in the study of neurodegenerative diseases using reduction techniques such as principal component analysis (PCA) and sparse inverse covariance estimation (SICE) in positron emission tomography (PET) data. In a recent study on Parkinson's disease (PD) patients, SICE combined with PCA was used to optimize maps of functional metabolic connectivity and identify key regional hubs and their connections in the brain. This approach revealed a core subnetwork that remained consistent across PD patients and could serve as a target for disease modification.

NEUROIMAGE-CLINICAL (2023)

Article Clinical Neurology

Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease

Aron Emmi, Michele Sandre, Francesco Paolo Russo, Giulia Tombesi, Federica Garri, Marta Campagnolo, Miryam Carecchio, Roberta Biundo, Gaya Spolverato, Veronica Macchi, Edoardo Savarino, Fabio Farinati, Piero Parchi, Andrea Porzionato, Luigi Bubacco, Raffaele De Caro, Gabor G. Kovacs, Angelo Antonini

Summary: This study investigated the alterations of alpha-synuclein and glial responses in duodenum biopsies of Parkinson's disease (PD) patients. The findings provide evidence of synuclein pathology and gliosis in the duodenum of PD patients, including early cases, suggesting the important role of the gut in PD pathogenesis.

MOVEMENT DISORDERS (2023)

No Data Available